This message was sent to ##Email##
|
|
|
|
| |
ITNS
The International Transplant Nurses Society's Annual Meeting Planning Committee invites you to submit an abstract for the Virtual Annual Meeting from Thursday, Oct. 22 — Sunday, Oct. 25, 2020.
The online meeting format gives the planning committee the opportunity to add late-breaking educational sessions to the program. Although we won't see each other in-person this year, we're hopeful this gives many an opportunity to present. Submit an abstract.
The Apopka Voice
The AdventHealth Transplant Institute Cardiothoracic program performed the first heart transplant in Florida through a process known as Donation after Circulatory Death (DCD). The team utilized a donor heart that was no longer beating and was evaluated via a groundbreaking process under a clinical FDA investigation.
DCD heart transplantation gives hope to patients and physicians faced with a growing organ shortage across America.
READ MORE
Live Science
The first COVID-19 patient in the U.S. to receive a double-lung transplant was discharged from the hospital this week, according to news reports.
After the coronavirus inflicted irreversible damage to her lungs, 28-year-old Mayra Ramirez underwent the transplant on June 5, Live Science previously reported. To qualify for the procedure, she first had to test negative for the virus, as transplant patients must take immune-suppressing drugs following the surgery.
READ MORE
|
Promoted by
|
|
|
|
 |
TMR BLOG
Removing immune cells from a donor heart using a new technique reduces the risk of acute rejection, even without the power of immunosuppressant drugs, says a new study at the University of Manchester. Called ex-vivo heart perfusion, the technique secures and restores the heart after it is removed from the donor. And, it extends the preservation time of organs from the current four to 24 hours.
READ MORE
WMAZ-TV
There is surely a point when acquaintances cross over into friends.
Debbie Lundberg and Debra Palmer crossed that line the day after they ate lunch together in 2019.
Lundberg, who moved to Florida in 2002, first read about Palmer's need for a kidney transplant in a Facebook post in 2019. Palmer has been dealing with persistent kidney problems for more two decades.
READ MORE
 |
|
Promoted by
Veloxis Pharmaceuticals
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
|
|
POZ
People with HIV and end-stage kidney disease can safely receive a kidney transplant from an HIV-positive deceased donor.
This finding from a study conducted by the HOPE in Action team indicates that the kidney donor pool for people with HIV who are awaiting a new organ can be expanded. This is particularly welcome news because as the HIV population ages, kidney disease among them will only rise.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Did you know there’s a transplant support system to help patients and providers with best-in-class assistance and resources? This ongoing support system assists with benefit investigation, prior authorization assistance, coordination with specialty pharmacies, prescription fulfillment navigation, and CoverMyMeds® access. There’s also a $0 co-pay card to overcome financial barriers.
Find out more
|
WKRG-TV
At 17 years old, Cooper Pierce received a double-lung and heart transplant. Now, he is 19 and gearing up for his sophomore year at UAB.
Early on, Pierce noticed his heart beating irregularly. Up until he was 13, he accredited his breathing problems to asthma, a misdiagnosis. Pierce said his family then took him for a checkup where the doctor immediately noticed something was wrong.
READ MORE
Hep Treatment News
Non-alcoholic steatohepatitis (NASH) is the second most common — and fastest-growing — indication for liver transplants in the United States, according to a study in Clinical Gastroenterology and Hepatology. Moreover, among women without hepatocellular carcinoma (HCC), NASH is already the leading reason for a liver transplant.
Changing trends in obesity and the development of better treatments for viral hepatitis have altered the picture of chronic liver disease in the United States.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
